Elan Corp. plc's sales and marketing update

Syntex Corp.'s Pharmaceuticals International Ltd. has acquired exclusive U.S. marketing rights to Elan Corp. plc's (ELN) Naprelan, a once-daily, controlled release formulation of naproxen, the Syntex-...